Exero Medical’s Smart Sensor Granted FDA Breakthrough Designation

Exero Medical, developer of a wireless system for early detection of anastomotic leaks (AL) following gastrointestinal (GI) surgery, today announced that it has been granted FDA Breakthrough Designation – a status reserved for medical devices that provide more effective treatment or diagnosis of potentially life-threatening or irreversible conditions or diseases.